Status:
COMPLETED
An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).
Eligibility Criteria
Inclusion
- Patients who are obese (considerably overweight) based on body mass index.
Exclusion
- Patients with serious or unstable current or past medical conditions
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00109148
Start Date
July 1 2004
End Date
February 1 2005
Last Update
September 9 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.